Pharmacokinetics/Pharmacodynamics Integration of Florfenicol against E.coli in Pigs ex vivo
Zeng ZhenLing
Abstract
Zeng ZhenLing
Abstract
For the rational usage of florfenicol to treat the colibacillosis of pigs,the integration of pharmacokinetics in vivo and pharmacodynamics in vitro was used to study the antibacterial activity of florfenicol against E.coli in pig serum ex vivo.The accurate MIC of florfenicol against E.coli in MH broth and serum was 3.25 and 8.75 μg·mL-1,respectively.Florfenicol was absorbed slowly and anomaly in pigs after intramuscular administration(20 mg·kg-1).The Cmax was(5.28±1.48) μg·mL-1 at(3.60±1.52) h.The elimination of florfenicol was slow in pigs.Mean residence time(MRT) was(26.61±9.81) h.Elimination half-life(t1/2β) was(17.49±8.04) h.EC50 was(7.76±4.53) h.AUC0→24/MIC was(7.69±1.48) h and Cmax/MIC was(0.60±0.17).Because of the poor activity of florfenicol against E.coli and the lower plasma Cmax of florfenicol in pigs,it may fail to get desirable treatment result when curing the infection of E.coli in pigs by the routine regimen.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
For the rational usage of florfenicol to treat the colibacillosis of pigs,the integration of pharmacokinetics in vivo and pharmacodynamics in vitro was used to study the antibacterial activity of florfenicol against E.coli in pig serum ex vivo.The accurate MIC of florfenicol against E.coli in MH broth and serum was 3.25 and 8.75 μg·mL-1,respectively.Florfenicol was absorbed slowly and anomaly in pigs after intramuscular administration(20 mg·kg-1).The Cmax was(5.28±1.48) μg·mL-1 at(3.60±1.52) h.The elimination of florfenicol was slow in pigs.Mean residence time(MRT) was(26.61±9.81) h.Elimination half-life(t1/2β) was(17.49±8.04) h.EC50 was(7.76±4.53) h.AUC0→24/MIC was(7.69±1.48) h and Cmax/MIC was(0.60±0.17).Because of the poor activity of florfenicol against E.coli and the lower plasma Cmax of florfenicol in pigs,it may fail to get desirable treatment result when curing the infection of E.coli in pigs by the routine regimen.
Key concepts: Florfenicol, Cmax, Pharmacokinetics, Pharmacology, Pharmacodynamics, In vivo, Biology, Ex vivo